middl
east
respiratori
syndrom
mer
emerg
respiratori
diseas
caus
mer
coronaviru
merscov
endem
saudi
arabia
sinc
danielsson
et
al
zaki
et
al
assiri
et
al
de
groot
et
al
azhar
et
al
may
confirm
case
countri
result
death
world
health
organ
middl
east
respiratori
syndrom
coronaviru
merscov
http
wwwwhointemergenciesmerscoven
dromedari
camel
primari
reservoir
merscov
evid
circul
viru
camel
saudi
arabia
sinc
least
hemida
et
al
kupferschmidt
alagaili
et
al
azhar
et
al
haagman
et
al
merscov
transmit
human
close
contact
dromedari
suggest
mer
zoonot
diseas
azhar
et
al
seroposit
rate
dromedari
camel
quit
high
middl
east
northern
eastern
african
countri
hemida
et
al
muller
et
al
miguel
et
al
fukushi
et
al
harcourt
et
al
lower
rate
seen
outsid
region
rang
tunisia
canari
island
reusken
et
al
gutierrez
et
al
furthermor
dromedari
australia
japan
shown
free
merscov
infect
hemida
et
al
shirato
et
al
despit
widespread
seroposit
merscov
report
dromedari
throughout
middl
east
north
africa
east
africa
human
mer
case
observ
middl
east
human
case
report
africa
date
test
patient
exposur
liljand
et
al
report
two
case
seroposit
among
specimen
test
kenya
howev
seroposit
rate
among
patient
kenya
similar
observ
saudi
arabia
muller
et
al
suggest
similar
rate
exposur
popul
differ
access
public
health
facil
region
propos
possibl
explan
wide
dispar
merscov
case
liljand
et
al
definit
caus
remain
unclear
although
underreport
may
account
differ
report
rate
hypothes
virolog
differ
african
middl
eastern
merscov
strain
may
play
role
human
merscov
infect
test
hypothesi
analyz
viral
properti
african
merscov
obtain
nasal
specimen
young
dromedari
year
old
afar
region
ethiopia
pay
special
attent
spike
protein
vero
cell
obtain
american
tissu
cultur
collect
atcc
cultur
dulbecco
modifi
eagl
medium
dmem
sigmaaldrich
st
loui
mo
usa
supplement
fetal
calf
serum
fcsdmem
cell
constitut
express
type
ii
transmembran
serin
proteas
shirogan
et
al
enhanc
cell
entri
fusion
format
merscov
gierer
et
al
shirato
et
al
maintain
fcsdmem
contain
mgml
enzo
biochem
new
york
ny
usa
bhk
cell
obtain
health
scienc
research
resourc
bank
hsrrb
osaka
japan
maintain
fcsmem
cell
maintain
institut
cultur
fcsdmem
merscov
emc
isol
kindli
provid
ron
fouchier
erasmu
medic
center
rotterdam
netherland
merscov
propag
titrat
use
cell
describ
previous
shirato
et
al
viral
titer
express
plaqu
form
unit
pfu
merscov
includ
recombin
handl
laboratori
approv
committe
biorisk
manag
nation
institut
infecti
diseas
sera
collect
dromedari
afar
region
ethiopia
march
august
fukushi
et
al
total
dromedari
sampl
includ
femal
male
median
age
year
age
sex
anim
unknown
nasal
swab
collect
dromedari
year
age
four
locat
awash
amibara
gewan
semera
afar
region
august
specimen
collect
dromedari
use
steril
omni
swab
ge
healthcar
chicago
il
usa
wet
distil
water
sampl
swab
immedi
spot
onto
fta
classic
card
color
indic
ge
healthcar
local
point
store
multibarri
pouch
ge
healthcar
contain
desicc
packet
ge
healthcar
use
rna
extract
spot
fta
card
punch
four
time
use
harri
unicor
punch
mm
ge
healthcar
punch
card
resuspend
ave
buffer
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
total
rna
isol
accord
manufactur
instruct
merscov
rna
detect
use
two
qprobe
rtlamp
assay
target
nucleocapsid
n
open
read
frame
orf
shirato
et
al
two
corman
realtim
rtpcr
assay
upe
corman
et
al
b
accord
case
definit
detect
least
two
distinct
genom
target
requir
posit
diagnosi
gar
revis
interim
case
definit
report
middl
east
respiratori
syndrom
coronaviru
merscov
updat
juli
http
wwwwhointcsrdiseasecoronavirusinfectionscasedefinitionenindexhtml
region
target
four
primer
set
includ
corman
assay
qprobe
rtlamp
assay
differ
posit
emc
isol
follow
upe
corman
n
lamp
supplementari
figur
therefor
posit
result
least
two
four
test
fulfil
criteria
specimen
consid
posit
merscov
studi
two
qprobe
rtlamp
assay
perform
first
screen
test
detect
ethiopian
merscov
rna
within
min
use
lyophil
reagent
batterydriven
portabl
tube
scanner
esequ
qiagen
without
larg
realtim
rtpcr
instrument
specimen
show
posit
qprobe
rtlamp
assay
consid
posit
merscov
rtlamp
screen
specimen
posit
either
n
retest
realtim
rtpcr
target
upe
equip
laboratori
specimen
posit
least
one
corman
assay
also
consid
posit
merscov
specimen
posit
detect
two
differ
genet
target
qprobe
rtlamp
assay
requir
regent
prepar
tube
strip
ina
optika
osaka
japan
lyophil
suppli
eiken
chemic
co
ltd
tokyo
japan
two
qprobe
rtlamp
primer
set
prepar
separ
well
extract
rna
dilut
ambion
nucleasefre
water
thermo
fisher
scientif
waltham
usa
half
mixtur
transfer
well
contain
dri
reagent
specimen
immedi
evalu
use
esequ
tube
scanner
qiagen
two
corman
realtim
rtpcr
assay
target
upe
corman
et
al
b
perform
use
quantitect
probe
rtpcr
kit
qiagen
lightcycl
instrument
roch
basel
switzerland
nearli
complet
genom
ethiopian
merscov
analyz
rna
sequenc
extract
viral
rna
revers
transcrib
tag
index
adaptor
use
nebnext
ultra
ii
rna
librari
prep
kit
illumina
new
england
biolab
ipswich
usa
accord
manufactur
instruct
result
cdna
librari
verifi
gel
electrophoresi
quantifi
use
quantu
fluoromet
promega
madison
wi
usa
index
librari
pool
sequenc
pairedend
read
use
miseq
illumina
inc
san
diego
ca
usa
hiseq
x
ten
system
illumina
inc
oper
genewiz
south
plainfield
nj
usa
sequenc
read
trim
map
emc
isol
genbank
access
refer
genom
use
clc
genom
workbench
softwar
clc
bio
aarhu
denmark
default
set
except
trim
q
read
length
bp
final
two
fulllength
genom
sequenc
obtain
deposit
genbank
access
no
phylogenet
analysi
perform
use
mega
softwar
ver
kumar
et
al
maximum
likelihood
method
bootstrap
test
gene
recombin
experi
perform
approv
committe
experi
use
recombin
dna
pathogen
nation
institut
infecti
diseas
novemb
confirm
research
promot
bureau
ministri
educ
cultur
sport
scienc
technolog
japan
novemb
recombin
merscov
gener
bacteri
artifici
chromosom
bac
clone
carri
fulllength
infecti
genom
emc
isol
design
pbacmerswt
describ
previous
terada
et
al
matsuyama
et
al
modif
protein
sequenc
amibara
isol
synthes
two
fragment
geneart
gene
synthesi
thermo
fisher
scientif
insert
vector
saijo
et
al
use
infus
hd
clone
kit
takara
bio
shiga
japan
plasmid
contain
chimer
protein
replac
emc
amibara
sequenc
first
furin
site
amino
acid
posit
protein
see
supplementari
figur
mark
boundari
region
construct
protein
sequenc
pbacmerswt
replac
use
redet
recombin
system
counterselect
bac
modif
kit
gene
bridg
heidelberg
germani
bhk
cell
grown
singl
well
sixwel
plate
fcsmem
transfect
bac
plasmid
lipofectamin
thermo
fisher
scientif
transfect
cell
detach
singl
well
sixwel
plate
use
cell
dissoci
solut
nonenzymat
sigmaaldrich
resuspend
fresh
medium
ad
transfect
bhk
cell
cocultur
incub
cell
fusion
form
fusion
supernat
collect
propag
use
cell
store
work
stock
evalu
viral
growth
cell
cultur
plate
infect
pfu
viru
min
adsorpt
cell
wash
twice
pb
dmem
contain
tryptos
phosphat
broth
tpb
sigmaaldrich
ad
indic
time
point
supernat
collect
titrat
use
cell
describ
previous
shirato
et
al
briefli
cell
form
plate
serial
dilut
supernat
inocul
onto
cell
min
adsorpt
cell
wash
pb
twice
incub
tpbdmem
h
incub
cell
fix
formalin
solut
wako
pure
chemic
industri
ltd
osaka
japan
ultraviolet
light
fix
cell
stain
crystal
violet
number
cell
fusion
count
microscop
analysi
viral
entri
pfu
viru
appli
vero
cell
plate
incub
viru
inocul
cellular
rna
collect
per
hour
use
cellamp
direct
rna
prep
kit
takara
bio
h
cell
lyse
process
buffer
lysat
mix
distil
water
aliquot
dilut
rna
use
realtim
rtpcr
virus
detect
indirectli
measur
subgenom
use
taqman
fast
viru
master
mix
thermo
fisher
scientif
follow
primer
probe
forward
primer
revers
primer
probe
copi
number
calcul
base
standard
curv
gener
realtim
rtpcr
use
synthes
control
rna
express
copieswel
neutral
assay
sera
obtain
dromedari
describ
use
along
mice
immun
em
isol
wild
type
iwatayoshikawa
et
al
neutral
assay
merscov
perform
use
cell
describ
shirato
et
al
minor
modif
serial
dilut
sera
mix
pfu
target
virus
tpbdmem
incub
room
temperatur
min
mixtur
appli
cell
plate
incub
h
fix
formalin
solut
wako
pure
chemic
industri
ultraviolet
light
fix
cell
stain
crystal
violet
number
cell
fusion
count
microscop
nonserum
sampl
use
neg
control
serum
dilut
show
neutral
rel
neg
control
consid
antibodi
titer
specimen
show
neutral
dilut
rel
neg
control
consid
posit
merscov
infect
dot
plot
graph
drawn
use
kaleidagraph
ver
synergi
softwar
mt
penn
pa
usa
unpair
test
student
welch
use
assess
statist
signific
differ
group
analys
p
taken
indic
statist
signific
merscov
highli
preval
north
east
africa
hemida
et
al
muller
et
al
miguel
et
al
dromedari
exhibit
seroposit
merscov
ethiopia
use
previous
collect
sera
dromedari
afar
region
ethiopia
fukushi
et
al
first
evalu
seroposit
merscov
anim
neutral
assay
use
wildtyp
emc
isol
figur
total
sera
test
confirm
posit
merscov
averag
titer
consist
studi
miguel
et
al
figur
stratifi
age
dromedari
year
age
test
posit
merscov
consist
previou
result
werneri
et
al
almost
half
sampl
test
exhibit
antibodi
titer
figur
c
titer
dromedari
year
age
tend
higher
seen
younger
anim
averag
titer
vs
respect
p
figur
taken
togeth
report
strongli
support
notion
merscov
endem
ethiopian
dromedari
report
werneri
et
al
dromedari
year
age
test
posit
viral
isol
viral
rna
highest
level
observ
anim
year
old
despit
higher
seroposit
rate
older
anim
base
observ
collect
nasal
specimen
dromedari
year
age
total
specimen
collect
specimen
come
anim
year
old
merscov
rna
detect
use
genet
diagnost
method
shown
tabl
specimen
confirm
posit
merscov
rtlamp
assay
n
specimen
posit
singl
gene
rtlamp
assay
analyz
realtim
rtpcr
assay
upe
reveal
four
addit
posit
specimen
final
posit
rate
specimen
merscov
result
similar
ethiopian
mer
studi
report
miguel
et
al
posit
specimen
detect
amibara
afar
region
japan
one
foot
mouth
diseas
fmd
free
countri
import
live
camel
materi
ethiopia
prohibit
therefor
fta
classic
card
use
studi
fix
specimen
immedi
pastor
farm
ethiopia
rna
extract
specimen
perform
addi
ababa
ethiopia
sequenc
analysi
perform
japan
therefor
rna
fragment
could
use
pcr
amplif
next
gener
sequenc
analysi
describ
cotten
et
al
determin
genom
sequenc
specimen
rna
sequenc
perform
among
posit
specimen
readili
detect
earli
time
point
rtlamp
suggest
high
viral
titer
specimen
nearli
fulllength
genom
sequenc
detect
two
specimen
use
miseq
two
specimen
subject
hiseq
analysi
increas
accuraci
reliabl
sequenc
final
two
independ
genom
sequenc
obtain
design
phylogenet
analys
perform
use
fulllength
sequenc
show
amibara
isol
cluster
alongsid
clade
c
isol
subclust
alongsid
ethiopian
isol
figur
chu
et
al
report
west
african
merscov
harbor
nucleotid
delet
rel
emc
isol
chu
et
al
contrast
amibara
isol
two
amino
acid
delet
end
instead
larg
delet
despit
evid
amino
acid
delet
chang
predict
affect
function
suggest
similar
activ
east
african
merscov
isol
kiambi
et
al
furthermor
phylogenet
analysi
perform
use
spike
protein
import
protein
involv
viral
infect
neutral
also
show
similar
cluster
isol
suggest
genom
attribut
east
african
merscov
present
protein
figur
protein
coronaviru
show
varieti
biolog
function
bind
receptor
wherea
respons
fusion
activ
sturman
et
al
spaan
et
al
kubo
et
al
protein
also
harbor
neutral
antibodi
epitop
associ
pathogen
spaan
et
al
takaseyoden
et
al
kubo
et
al
holm
compton
variat
protein
therefor
thought
directli
influenc
import
biolog
characterist
viru
pathogen
antigen
evalu
role
protein
amibara
isol
recombin
merscov
gener
use
bac
vector
system
terada
et
al
matsuyama
et
al
protein
sequenc
emc
isol
replac
amibara
isol
design
figur
replic
rate
amibara
recombin
log
lower
emc
vero
cell
day
postinfect
figur
contrast
shown
enhanc
viral
entri
replic
merscov
gierer
et
al
shirato
et
al
although
peak
titer
recombin
cell
similar
slight
delay
replic
amibara
recombin
postinfect
figur
immort
human
airway
epitheli
cell
line
express
high
level
commonli
use
studi
respiratori
pathogen
due
abil
mimic
human
airway
tissu
like
cell
cell
exhibit
similar
final
viral
titer
peak
although
amibara
recombin
replic
slowli
emc
recombin
figur
result
show
protein
ethiopian
merscov
associ
slower
viral
replic
next
viral
entri
determin
emc
amibara
recombin
measur
subgenom
mrna
figur
cell
level
viral
entri
ident
emc
recombin
h
postinocul
level
becam
slightli
higher
emc
recombin
figur
contrast
quantif
viral
entri
reveal
lower
level
recombin
h
postinocul
vero
cell
em
recombin
figur
observ
suggest
differ
viral
replic
may
attribut
slight
differ
viral
entri
describ
protein
primari
target
neutral
antibodi
test
strainspecif
differ
antibodi
respons
neutral
assay
examin
reactiv
amibara
recombin
perform
use
sera
obtain
ethiopian
dromedari
describ
figur
figur
sera
six
differ
anim
use
titer
rang
differ
reactiv
calcul
rel
emc
isol
expect
neutral
titer
emc
recombin
similar
emc
isol
wild
type
contrast
neutral
titer
amibara
recombin
two
fourfold
higher
dilut
sera
mean
amibara
recombin
effect
neutral
use
significantli
lower
antibodi
level
need
emc
recombin
although
collect
date
differ
sera
use
assay
obtain
area
afar
region
ethiopia
amibara
isol
addit
camel
export
ethiopia
middl
east
gener
return
ethiopia
fay
eshetu
abraham
unlik
camel
carri
middl
eastern
merscov
would
affect
serolog
ethiopia
addit
though
yearli
chang
ethiopian
merscov
unknown
due
shortag
genom
sequenc
databas
neighbor
countri
kenya
amino
acid
sequenc
region
ident
among
isol
genbank
access
no
data
shown
rais
possibl
antigen
stabil
geograph
area
east
africa
therefor
believ
littl
diverg
sera
collect
collect
ethiopia
immun
respons
merscov
dromedari
afar
like
close
relat
amibara
isol
emc
isol
thu
suspect
may
differ
antigen
emc
amibara
protein
therefor
perform
second
neutral
assay
mice
use
sera
deriv
mice
inocul
emc
isol
iwatayoshikawa
et
al
figur
sera
five
mice
use
evalu
contrast
initi
suspicion
neutral
assay
show
similar
kinet
present
figur
ie
amibara
recombin
strain
effect
neutral
use
lower
antibodi
concentr
use
emc
recombin
even
emcimmun
mous
sera
thu
although
protein
sequenc
amibara
isol
might
differ
camel
sera
collect
regardless
neutral
profil
among
amibara
emc
protein
clearli
differ
result
suggest
antigen
emc
amibara
protein
differ
amibara
protein
readili
neutral
merscovantibodi
emc
protein
next
assess
contribut
protein
neutral
kinet
number
differ
amino
acid
emc
amibara
protein
supplementari
figur
differ
present
region
therefor
recombin
viru
strain
express
chimer
protein
gener
interchang
region
emc
amibara
protein
replac
perform
first
furin
site
mark
junction
region
yield
recombin
harbor
chimer
protein
design
neutral
assay
perform
use
dromedari
sera
describ
figur
result
show
neutral
kinet
depend
primarili
region
neutral
titer
emc
significantli
lower
emc
observ
indic
differ
neutral
profil
emc
amibara
protein
depend
region
studi
perform
identifi
viralspecif
differ
merscov
isol
could
account
absenc
human
infect
africa
despit
similar
preval
merscov
east
north
african
dromedari
protein
ethiopian
merscov
isol
shown
confer
slow
viral
replic
cell
easili
neutral
respons
antibodi
rel
emc
isol
find
suggest
differ
viral
replic
neutral
properti
emc
ethiopian
merscov
isol
may
explain
mark
discrep
human
case
region
result
studi
show
ethiopian
dromedari
highli
infect
merscov
miguel
et
al
current
state
human
merscov
infect
ethiopia
unclear
due
lack
adequ
surveil
studi
report
seroposit
rate
human
neighbor
countri
kenya
provid
baselin
assess
viral
exposur
liljand
et
al
viral
replic
rate
eas
neutral
differ
amibara
emc
recombin
suggest
ethiopian
merscov
may
less
virul
human
due
accumul
small
differ
dromedari
commonli
export
ethiopia
middl
east
meat
milk
product
purpos
consum
final
destin
fay
eshetu
abraham
although
export
dromedari
may
harbor
ethiopian
merscov
variant
ethiopian
strain
may
like
overtaken
middl
eastern
strain
similar
emc
strain
due
variat
confer
lower
replic
rate
higher
immun
clearanc
rate
unidirect
natur
dromedari
trade
natur
regionspecif
merscov
variant
like
may
explain
human
merscov
case
remain
restrict
middl
east
one
import
find
studi
virolog
differ
ethiopian
emc
isol
base
protein
coronavir
protein
strongli
associ
viral
pathogen
spaan
et
al
follow
infect
viral
protein
cleav
hostderiv
proteas
two
subunit
respons
receptor
bind
neutral
respons
fusion
activ
sturman
et
al
spaan
et
al
kubo
et
al
number
amino
acid
differ
emc
amibara
protein
supplementari
figur
differ
local
region
receptor
bind
domain
rbd
also
found
region
amino
acid
chen
et
al
lu
et
al
mou
et
al
wang
et
al
result
present
show
amibara
suscept
antibodi
neutral
emc
protein
major
neutral
antibodi
work
bind
rbd
serv
competit
inhibitor
merscov
receptor
dipeptidyl
peptidas
li
et
al
yu
et
al
chen
et
al
wang
et
al
induc
conform
chang
protein
zhang
et
al
amino
acid
differ
rbd
emc
amibara
protein
although
residu
direct
contact
wang
et
al
zhang
et
al
substitut
region
may
affect
antibodi
bind
affin
contrast
region
region
affect
viral
entri
follow
cleavag
host
proteas
coinfect
bacteria
matsuyama
et
al
ami
et
al
kawas
et
al
shirato
et
al
cov
protein
thought
cleav
around
first
furin
site
healdsarg
gallagh
although
cov
lack
furin
cleavag
site
three
amino
acid
differ
region
emc
amibara
protein
substitut
occur
upstream
second
furin
site
site
locat
immedi
upstream
put
fusion
peptid
coronavir
spike
protein
madu
et
al
cleavag
posit
lead
import
conform
chang
park
et
al
matsuyama
et
al
therefor
mutat
may
result
differ
viral
entri
emc
amibara
recombin
howev
report
previous
although
proteas
sensit
human
coronaviru
hcov
protein
differ
celladapt
laboratori
strain
clinic
isol
differ
longer
appar
replac
two
amino
acid
region
shirato
et
al
similarli
differ
macrophag
infect
felin
enter
coronaviru
fecv
nonsuscept
felin
infecti
periton
viru
fipv
suscept
disappear
introduc
five
amino
acid
substitut
shirato
et
al
taken
togeth
singl
mutat
combin
mutat
found
protein
suggest
clear
differ
associ
viral
infect
virul
trait
work
remain
done
elucid
underli
caus
proteinderiv
pathogen
amibara
isol
use
recombin
merscov
strain
studi
focus
merscov
protein
determin
viral
pathogen
although
chu
et
al
suggest
possibl
involv
gene
lower
replic
west
african
merscov
chu
et
al
although
west
african
merscov
lack
gene
absenc
gene
result
higher
type
iii
interferon
respons
cell
suggest
potenti
contribut
lower
viral
replic
chu
et
al
differ
public
health
infrastructur
middl
eastern
african
countri
often
cite
main
caus
region
deviat
mer
case
howev
addit
report
chu
et
al
studi
provid
evid
region
differ
merscov
ethiopian
merscov
strain
exhibit
lower
replic
rate
greater
suscept
neutral
antibodi
emc
isol
addit
previou
genet
analysi
middl
eastern
isol
reveal
amino
acid
mutat
posit
protein
strong
select
variant
human
mer
case
sinc
first
appear
cotten
et
al
suggest
pathogen
transit
merscov
human
outbreak
middl
east
taken
togeth
observ
suggest
differ
public
health
infrastructur
also
virolog
differ
merscov
may
affect
region
differ
mer
case
taken
togeth
data
present
repres
first
demonstr
virolog
differ
ethiopian
merscov
emc
isol
driven
chang
protein
studi
necessari
fulli
elucid
pathogen
african
merscov
isol
dataset
gener
studi
includ
manuscript
andor
supplementari
file
studi
use
mice
specimen
obtain
previou
work
j
virol
pii
specimen
collect
ethic
approv
follow
experi
use
recombin
dna
pathogen
approv
committe
experi
use
recombin
dna
pathogen
nation
institut
infecti
diseas
tokyo
japan
anim
experi
approv
anim
care
use
committe
nation
institut
infecti
diseas
conduct
accord
institut
guidelin
care
use
anim
anim
hous
japan
health
scienc
foundationcertifi
facil
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
